mbiomics is a pioneer in targeted microbiome profiling. Our patented precision technology enables unparalleled quantitative resolution and drastically faster microbiome analysis. This creates a basis for various future clinical applications and it will accelerate microbiome-based therapeutics development.
We work with industry leaders across the medical, technology and biotechnology industries, as well as renowned academic institutions, on both clinical research and commercial product development.